Search Results 1531-1540 of 14735 for anti-TNF drugs
The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2 ...
However, depending on your needs, you may also have access to other drug therapies, such as immunotherapy and targeted drug therapy. Rehabilitation and overall ...
Participation eligibility · Age >18 years. · Histological confirmation of clinically HER2+ breast cancer · Scheduled to start anti-HER2 therapy, in combination ...
... anti-coagulant medication within 90 days of LP. NOTE: low dose aspirin is permitted); degenerative arthritis of the lumbar spine; suspected non ...
Bronchodilators are medicines that relax the muscles in the bronchial tubes (air passages) of the lungs. They relieve cough, wheezing, shortness of breath, and ...
His principal research interests are developing and optimizing novel-engineered cell therapy approaches for the treatment of diseases. Research in the T Cell ...
By condition, treatment or drug name. Search ... Drugs used in chemotherapy, such as temozolomide ... anti-cytotoxic T-lymphocyte antigen 4 (CTLA4) ...
Our multidisciplinary team model lets us leverage recent breast cancer treatment advances to develop a personalized comprehensive treatment plan. A surgeon and ...
Participation eligibility · Anti-platelet therapy on admission or within 7 days prior to admission · Presented to outside hospital ED > 12 hrs before arrival at ...
Salvage therapy · Report and describe patient-reported functional outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.